Trial Profile
Comparison of adherence and persistence associated with nebivolol or hydrochlorothiazide as add-on treatment for hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Hydrochlorothiazide (Primary) ; Nebivolol (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 13 Dec 2015 New trial record